Skip to main content
Contact +1 (919) 234-1277

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Denosumab Biosimilar – Anti-RANKL mAb – Research Grade

Isotype:
IgG2, Kappa

$143.00

100ug + 143 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
Denosumab Biosimilar – Anti-RANKL mAb – Research Grade binds to CD254 / RANKL / TNFSF11, N-Fc, recombinant protein in indirect ELISA Assay

Denosumab Biosimilar - Anti-RANKL mAb - Research Grade

Product name Denosumab Biosimilar - Anti-RANKL mAb - Research Grade
Source DrugBank DB06643
Species Human
Molecular weight 144kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Denosumab,Denosumab,RANKL,anti-RANKL
Reference PX-TA1018
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG2Kappa
Clonality Monoclonal Antibody
Product name Denosumab Biosimilar - Anti-RANKL mAb - Research Grade
Source DrugBank DB06643
Species Human
Molecular weight 144kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Denosumab,Denosumab,RANKL,anti-RANKL
Reference PX-TA1018
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG2Kappa
Clonality Monoclonal Antibody

General information about Denosumab

Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption markers in patients with a variety of metastatic tumors and is being investigated in multiple clinical trials for the prevention and treatment of bone metastases. Chemically, it consists of 2 heavy and 2 light chains. Each light chain consists of 215 amino acids. Each heavy chain consists of 448 amino acids with 4 intramolecular disulfides.This product is for research use only.

Denosumab Biosimilar – Anti-RANKL mAb – Research Grade binds to CD254 / RANKL / TNFSF11, N-Fc, recombinant protein in indirect ELISA Assay

Denosumab Biosimilar – Anti-RANKL mAb – Research Grade binds to CD254 / RANKL / TNFSF11, N-Fc, recombinant protein in indirect ELISA Assay

Immobilized CD254 / RANKL / TNFSF11, N-Fc, recombinant protein (cat. No.PX-P5597) at 5µg/mL (100µL/well) can bind to Denosumab Biosimilar- Anti-RANKL mAb- Research Grade (cat. No.PX-TA1018) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Denosumab Biosimilar – Anti-RANKL mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products